Immunofluorescence detection in the hippocampus showed that the relative fluorescence intensity of AD-associated p-Tau (Ser396 and AT8) was significantly decreased in the hDPSCs-treated AD mice (Figure 2A, B and S3B). Here, MAPT is linked to Alzheimer disease.